SciVision Biotech Inc.

1786

TW0001786002

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
108 ^TWD	-1.37%		+3.85%	+39.18%

Apr. 10	SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses	CI
Apr. 09	Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices	CI

SciVision Biotech Inc.(TWSE:1786) dropped from S&P Global BMI Index

September 19, 2022 at 12:00 am EDT

Latest news about SciVision Biotech Inc.

SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses	Apr. 10	CI
Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices	Apr. 09	CI
SciVision Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
SciVision Biotech Inc.(TWSE:1786) added to S&P Global BMI Index	23-09-18	CI
SciVision Biotech Inc.'s Product, Cross-Linked Hyaluronic Acid Synovial Fluid Supplement ?Hyajoint Plus? Obtains Medical Device License	23-09-05	CI
SciVision Biotech Inc. Announces Corporate Governance Officer Changes	23-08-10	CI
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
SciVision Biotech Inc. Approves Cash Dividend, Payable on August 18, 2023	23-06-28	CI
SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
SciVision Biotech Inc.(TWSE:1786) dropped from S&P Global BMI Index	22-09-19	CI
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-03	CI
SciVision Biotech Inc. Announces Cash Dividend, Payable on August 18, 2022	22-06-29	CI
SciVision Biotech Inc. Announces Hyaluronic Acid Flexotron Forte (1%) Has Obtained Medical Device License	22-06-09	CI
SciVision Biotech Inc. Announces Executive Changes	22-05-26	CI
SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
SciVision Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23	CI
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-03	CI
Scivision Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-04	CI
Scivision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-05	CI
Scivision Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-24	CI
Scivision Biotech Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-04	CI
Scivision Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-05	CI
Scivision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-06	CI

SciVision Biotech Inc is principally engaged in the manufacturing and distribution of hyaluronic acid medical supplies. The Company primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The Company is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The Company operates its business in the Americas, Europe, Asia, Middle East and Africa.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Devices & Implants

	1st Jan change	Capi.
SCIVISION BIOTECH INC.	+39.18%	224M
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B